benzyl isothiocyanate has been researched along with transforming growth factor beta in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sehrawat, A; Singh, SV | 1 |
1 other study(ies) available for benzyl isothiocyanate and transforming growth factor beta
Article | Year |
---|---|
Benzyl isothiocyanate inhibits epithelial-mesenchymal transition in cultured and xenografted human breast cancer cells.
Topics: Animals; Apoptosis; Blotting, Western; Breast Neoplasms; Cadherins; Cell Differentiation; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Humans; Immunoenzyme Techniques; Isothiocyanates; Membrane Proteins; Mice; Occludin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Transforming Growth Factor beta; Transplantation, Heterologous; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Vimentin | 2011 |